Wednesday, November 14, 2018 1:20:39 PM
Some news out:
EDMONTON, Nov. 14, 2018 /PRNewswire/ - Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce the appointment of Dr. Jonathan Page, PhD as the Company's Chief Science Officer.
https://mobile.tmxmoney.com/quote/readnews/?id=5920035200951206&symbol=ACB
EDMONTON, Nov. 14, 2018 /PRNewswire/ - Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce the appointment of Dr. Jonathan Page, PhD as the Company's Chief Science Officer.
https://mobile.tmxmoney.com/quote/readnews/?id=5920035200951206&symbol=ACB
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 11:29:57 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (US) • 03/30/2026 11:03:00 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (Canada) • 03/30/2026 11:03:00 AM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (US) • 02/17/2026 11:39:00 PM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (Canada) • 02/17/2026 11:39:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:26:03 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (US) • 02/12/2026 09:05:00 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (Canada) • 02/12/2026 09:05:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (Canada) • 02/11/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:44:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 02:45:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:27:19 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 02/04/2026 12:10:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:05:38 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (US) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program • PR Newswire (US) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Launches New European Websites, Showcasing Science-Backed Cannabis Leadership • PR Newswire (US) • 02/03/2026 12:00:00 PM
- Aurora Launches New European Websites, Showcasing Science-Backed Cannabis Leadership • PR Newswire (Canada) • 02/03/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/21/2026 10:17:54 PM
- Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call • PR Newswire (Canada) • 01/21/2026 09:35:00 PM
- Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties • PR Newswire (US) • 01/20/2026 12:00:00 PM
- Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties • PR Newswire (Canada) • 01/20/2026 12:00:00 PM
